• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
Codagenix, Inc. logo
Menu
  • Approach
  • Pipeline
  • Team
  • Careers
  • News
  • Publications
  • Contact
Back to news
Clinical Trials Arena
2022 / News Coverage

Codagenix and SII begin subject dosing in Phase III Covid-19 vaccine trial

Codagenix, Inc. logo
  • Approach
  • Pipeline
  • Team
  • Careers
  • News
  • Publications

Get in touch with us.

CONTACT US
Privacy Policy Terms & Conditions
© Codagenix 2022. All Rights Reserved.
Back to top